Le Lézard
Classified in: Health, Science and technology
Subjects: Stock Sale/Buyback, Share Issue

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that as an inducement to entering into employment with the Company, on April 1, 2022, the Compensation Committee of the Company's Board of Directors approved "inducement" grants to 23 new employees under Rule 5635(c)(4) of the NASDAQ Listing Rules. The grants entitle employees, in aggregate, to receive up to 53,000 restricted stock units. The grants are outside the Company's stockholder-approved equity incentive plans and vest annually over four years.

About Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep, and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Arrowhead's RNAi-based therapeutics leverage this natural pathway of gene silencing.

For more information, please visit www.arrowheadpharma.com, or follow us on Twitter @ArrowheadPharma. To be added to the Company's email list and receive news directly, please visit http://ir.arrowheadpharma.com/email-alerts.

Source: Arrowhead Pharmaceuticals, Inc.

These press releases may also interest you

at 15:34
CHOC Hospital has been granted Level 1 Children's Surgical Verification by the American College of Surgeons (ACS). This notable achievement acknowledges CHOC's steadfast commitment to quality improvement and patient safety efforts for children...

at 15:34
Audicus, the long-time provider and premier name in affordable, fully-customizable online hearing aids, celebrates the final FDA rule issued on Tuesday. The long-awaited rule, stemming from 2017 congressional legislation, establishes a new category...

at 15:24
The Tech Interactive has announced plans to create delightful and engaging resources for families to explore critical thinking and problem-solving skills through a new sponsorship from Stanford Medicine Children's Health. As part of the three-year...

at 15:23
During National Health Center Week observed recently, Fidelis Care, a New York State health plan with more than 2.5 million members, proudly recognized Federally Qualified Health Centers (FQHCs) and the vital work they do throughout the year....

at 15:12
Boston Heart Diagnostics, part of the Eurofins network of companies, announces the launch of LipidSeqtm, a revolutionary genetic test for cardiovascular disease. This saliva-based NGS test identifies the most common genetic causes of lipid and...

at 15:01
In a first-of-its-kind trial, a federal judge has ordered a $650.6 million judgment sought by two Ohio counties against retail giants CVS Health Corp., Walgreens Boots Alliance Inc and Walmart Inc. for their roles in failing to control the spread of...

News published on 6 april 2022 at 07:35 and distributed by: